Brainomix and Pulmonary Fibrosis Foundation Partner on AI Lung Imaging Research
Oct 14, 2026
Healthcare
Medtronic Leads $100 Million Strategic Investment in Pulnovo Medical
Apr 20, 2026
Pulnovo Medical has completed a $100 million strategic financing round led by Medtronic, with participation from existing and new investors. The two companies also signed a commercial agreement to explore future marketing opportunities for Pulnovo's pulmonary artery denervation system.
Pulnovo Medical has completed a 100 million dollar strategic financing round led by Medtronic, announced in a press release. Existing investors including EQT, Qiming Venture Partners, Gaorong Ventures, OrbiMed, and Lilly Asia Ventures also participated, along with new investors such as HSG and other global funds.
Pulnovo and Medtronic have signed a commercial agreement that outlines potential future marketing opportunities. The collaboration aims to leverage Medtronic's global commercial capabilities alongside Pulnovo's technology.
Pulnovo develops a patented pulmonary artery denervation (PADN) system designed to address key mechanisms in cardiopulmonary diseases. The company has conducted about 1,500 PADN procedures worldwide and secured regulatory approvals in seven countries. It is expanding commercialization in the European Union, the Middle East, and China.
In the United States, Pulnovo has received the FDA Breakthrough Device designation and launched two fully approved Investigational Device Exemption trials led by Dr. Gregg Stone of Mount Sinai.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Funding
Nov 12 Octave Acquires Cerebre for Industrial AI Plant Models Nov 11 StitchStudio raises $8M for insurance AI products Nov 11 Stage 2 Capital Closes $100 Million for B2B AI Investments Nov 11 Enza Capital secures $21 million for African AI fund Nov 11 Goldman Sachs Forecasts Anthropic Revenue of $685 Billion by 2030More from Life Sciences
Nov 11 Optum and Alameda Alliance Partner on AI Claims Automation Nov 11 Mosaic Raises $47M for Blood Vessel Surgery Robots Nov 11 Kardi AI Raises €5.3 Million for Heart Monitoring Expansion Nov 11 Switchpoint Bio raises $5.3 million for AI epigenomics platform Nov 10 Google Cloud Launches Gemini for Healthcare With HCA, Northwell and OptumFree newsletter
AI Funding Brief
Market report
.png)
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Sensydia Raises More Than $6 Million for AI Cardiac System
Oct 13, 2026
Funding
Laza Medical raises up to $160 million for cardiac imaging system
Nov 04, 2026
Funding
Adsilico Raises £10 Million for Virtual Medical Device Testing
Oct 27, 2026
Healthcare
Monopulse Raises Over €2 Million for Electronic Warfare Resistant Drones
Oct 13, 2026
Funding
Healthcare Triangle Identifies Up to $45 Million Indonesia Pipeline
Nov 02, 2026
Healthcare
Free, six days a week
Daily AI Brief: the AI news that matters, in your inbox.